Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Teva jumps ahead of Q3 results

Summary by Globes
Since the stock’s low-point in 2025 in April, the Israeli pharmaceutical company’s share price has risen over 60%.

2 Articles

GlobesGlobes
Center

Teva jumps ahead of Q3 results

Since the stock’s low-point in 2025 in April, the Israeli pharmaceutical company’s share price has risen over 60%.

Read Full Article
borsen.dkborsen.dk

Leo Pharma Hires Development Manager From Teva

Leo Pharma brings in development manager from TevaDenmark's oldest pharmaceutical group, Leo Pharma, has found its new development manager after just over half a year with a temporary solution in the position. It concerns br

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

borsen.dk broke the news in on Monday, November 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets icon

Stock Markets

Pharma icon

Pharma

Israel icon

Israel

Copenhagen icon

Copenhagen

Israel Economy icon

Israel Economy

Denmark Economy icon

Denmark Economy

News
For You
SearchBlindspotLocal